Blog The place to get DiaCarta’s updates and latest precision molecular diagnostics trends NGS test for colorectal cancer to guide targeted therapy by Admin | Apr 8, 2024read more Detection of ROS1, RET, and ALK fusions in non-small cell lung cancer by Admin | Apr 3, 2024read more Who should be tested for VEXAS syndrome? by Admin | Feb 14, 2024read more Genetic Testing for the VEXAS Syndrome by Admin | Feb 6, 2024read more What is VEXAS syndrome? by Admin | Jan 30, 2024read more Dealing with the Respiratory Viruses that Cause Covid-19 or Flu by Wei Liu, PhD | Sep 13, 2022read more Early Cancer Detection Will Save More Lives by Wei Liu, PhD | Nov 23, 2021read more Assay Detects Precancerous Colorectal Cancer Lesions & Mutations by Media Coverage | Oct 29, 2021read more DiaCarta Positioning Liquid Biopsy Assay to Gauge Chemotherapy Response in Multiple Cancers by Media Coverage | May 13, 2021read more « Older Entries
Detection of ROS1, RET, and ALK fusions in non-small cell lung cancer by Admin | Apr 3, 2024read more
Dealing with the Respiratory Viruses that Cause Covid-19 or Flu by Wei Liu, PhD | Sep 13, 2022read more
Assay Detects Precancerous Colorectal Cancer Lesions & Mutations by Media Coverage | Oct 29, 2021read more
DiaCarta Positioning Liquid Biopsy Assay to Gauge Chemotherapy Response in Multiple Cancers by Media Coverage | May 13, 2021read more